tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Oruka Therapeutics Inc

ORKA
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
88.550USD
-6.000-6.35%
์‹œ์žฅ ์šด์˜ ์‹œ๊ฐ„ย 09/23, 14:22๏ผˆET๏ผ‰
5.34B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Oruka Therapeutics Inc

88.550
-6.000-6.35%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

ORKA ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Oruka Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
5.34B
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-37.14
์ฃผ๋‹น์ˆœ์ด์ต
-2.38
์ˆ˜์ต
--
์ˆœ์ด์ต
-83.72M
ROE
-27.50%
ROA
-26.37%

Oruka Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 10, 2026
EPS / ์˜ˆ์ƒ
-0.66/-0.52
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-12.27%-0.66
-14.47%-0.58
7.80%-0.54
63.96%-0.69
73.65%-0.58
69.69%-0.50
35.08%-0.59
-60.77%-1.91
-79.73%-2.22
-48.31%-1.66
7.39%-0.91
---1.19
---1.23
---1.12
---0.98
---7.29
----
----
----
----
์ˆœ์ด์ต
-67.68%-41.21M
-51.53%-31.82M
-14.75%-29.58M
-5.78%-30.28M
-817.63%-24.57M
-945.25%-21.00M
-2267.40%-25.78M
-1910.04%-28.62M
-80.95%-2.68M
-49.26%-2.01M
7.24%-1.09M
38.96%-1.42M
52.97%-1.48M
58.86%-1.35M
79.32%-1.17M
50.49%-2.33M
34.90%-3.15M
20.20%-3.27M
-10.75%-5.68M
-136.66%-4.71M
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
----
--0.00%
--0.00%
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์˜์—… ์ด์ต
-76.25%-50.11M
-45.24%-36.43M
-13.57%-34.43M
-15.81%-34.10M
-810.60%-28.43M
-910.72%-25.09M
-1806.79%-30.32M
-1420.34%-29.45M
-58.24%-3.12M
-38.20%-2.48M
-2.71%-1.59M
24.10%-1.94M
38.71%-1.97M
45.19%-1.80M
72.75%-1.55M
45.89%-2.55M
33.45%-3.22M
20.11%-3.28M
-10.81%-5.68M
-136.98%-4.72M
์ˆœ์ด์ต
-67.68%-41.21M
-51.53%-31.82M
-14.75%-29.58M
-5.78%-30.28M
-817.63%-24.57M
-945.25%-21.00M
-2267.40%-25.78M
-1910.04%-28.62M
-80.95%-2.68M
-49.26%-2.01M
7.24%-1.09M
38.96%-1.42M
52.97%-1.48M
58.86%-1.35M
79.32%-1.17M
50.49%-2.33M
34.90%-3.15M
20.20%-3.27M
-10.75%-5.68M
-136.66%-4.71M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
166.42%884.56M
12.26%395.25M
-8.76%343.86M
-13.99%355.16M
881.70%332.01M
860.14%352.08M
902.52%376.87M
961.78%412.95M
-17.02%33.82M
-12.07%36.67M
-11.96%37.59M
-12.70%38.89M
-14.48%40.76M
-17.49%41.70M
-21.54%42.70M
-25.33%44.55M
-26.45%47.66M
-26.47%50.54M
8.91%54.42M
14.88%59.67M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
89.66%22.97M
41.88%16.63M
17.87%15.37M
16.23%20.97M
852.79%12.11M
641.49%11.72M
1947.57%13.04M
1718.45%18.04M
-20.66%1.27M
24.88%1.58M
-43.73%637.00K
-48.79%992.00K
-42.97%1.60M
-53.44%1.27M
-67.64%1.13M
-39.13%1.94M
-23.98%2.81M
-5.59%2.72M
-0.03%3.50M
108.38%3.18M
์ด ์ž์‚ฐ
218.78%1.14B
33.77%504.48M
23.38%488.62M
22.98%509.25M
956.07%357.42M
927.39%377.11M
945.98%396.02M
956.78%414.09M
-17.62%33.84M
-12.73%36.71M
-12.12%37.86M
-12.86%39.18M
-14.59%41.08M
-17.55%42.06M
-21.56%43.09M
-25.30%44.97M
-26.38%48.10M
-26.26%51.01M
8.91%54.92M
15.79%60.19M
๋ถ€์ฑ„ ์ด๊ณ„
80.35%24.84M
43.38%17.76M
20.94%16.69M
18.96%22.46M
983.87%13.78M
683.49%12.39M
1540.67%13.80M
1452.71%18.88M
-31.11%1.27M
3.47%1.58M
-40.44%841.00K
-45.67%1.22M
-41.20%1.84M
-50.33%1.53M
-63.62%1.41M
-37.69%2.24M
-24.02%3.14M
-6.05%3.08M
-0.69%3.88M
135.23%3.59M
์ž๋ณธ ์ด๊ณ„
224.33%1.11B
33.45%486.72M
23.47%471.93M
23.17%486.79M
954.99%343.64M
938.36%364.73M
932.47%382.22M
940.90%395.21M
-16.99%32.57M
-13.34%35.13M
-11.17%37.02M
-11.14%37.97M
-12.73%39.24M
-15.45%40.53M
-18.36%41.67M
-24.51%42.73M
-26.54%44.96M
-27.27%47.94M
9.72%51.04M
12.18%56.60M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
-43.21%-33.15M
-12.98%-23.58M
-20.07%-22.59M
38.03%-21.60M
-778.70%-23.14M
-1265.77%-20.87M
-1682.01%-18.82M
-1988.50%-34.86M
-279.54%-2.63M
4.20%-1.53M
29.32%-1.06M
33.19%-1.67M
73.53%-694.00K
62.89%-1.59M
69.80%-1.49M
48.71%-2.50M
29.52%-2.62M
17.74%-4.30M
-65.18%-4.95M
-143.26%-4.87M
์ˆœํˆฌ์ž
-8555.70%-410.95M
-133.68%-14.44M
93.33%-22.02M
-71507.60%-122.45M
--4.86M
--42.87M
---329.96M
---171.00K
--0.00
--0.00
--0.00
--0.00
--0.00
100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
66.67%-2.00K
46.15%-7.00K
---14.00K
์ˆœ์žฌ๋ฌดํ™œ๋™
608195.41%663.04M
--40.60M
156.65%298.00K
-62.25%169.91M
678.57%109.00K
----
---526.00K
--450.05M
--14.00K
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Oruka Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Oruka Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 343.86M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -8.76์ž…๋‹ˆ๋‹ค.

Oruka Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Oruka Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Oruka Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 488.62M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 23.38์ž…๋‹ˆ๋‹ค.

Oruka Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Oruka Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Oruka Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 16.69M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 20.94์ž…๋‹ˆ๋‹ค.

Oruka Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Oruka Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Oruka Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 471.93M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 23.47์ž…๋‹ˆ๋‹ค.

Oruka Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Oruka Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Oruka Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -122.05M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -38.50์ž…๋‹ˆ๋‹ค.

Oruka Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Oruka Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Oruka Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” -96.75M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 70.69์ž…๋‹ˆ๋‹ค.

Oruka Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Oruka Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Oruka Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 170.31M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -62.11์ž…๋‹ˆ๋‹ค.

Oruka Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Oruka Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -2.31์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 53.65์ž…๋‹ˆ๋‹ค.

Oruka Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Oruka Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -105.43M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -25.93์ž…๋‹ˆ๋‹ค.

Oruka Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Oruka Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -24.86์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 38.20์ž…๋‹ˆ๋‹ค.

Oruka Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Oruka Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -23.84์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 38.24์ž…๋‹ˆ๋‹ค.

Oruka Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Oruka Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -122.05M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -38.50์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ